Antihistamines in late-phase clinical development for allergic disease-Reference-Cited by-同舟云学术

Antihistamines in late-phase clinical development for allergic disease

Published:2002-02 Issue:2 Volume:11 Page:259-273
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Salmun Luis M¹

Affiliation:

1. Schering-Plough Research Institute, 2000 Galloping Hill Rd., Building K-5, 2nd Floor, Mailstop B-2, Kenilworth, NJ 07033, USA, Tel.: 908 298 5454; Fax: 908 298 7574;, E-mail: luis.salmun@spcorp.com

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.11.2.259

Reference82 articles.

1. Pharmacotherapy to Prevent the Complications of Allergic Rhinitis

2. Diagnosis and Management of Rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology

3. National guidelines needed to manage rhinitis and prevent complications

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiallergic Effects of Phenolic Compounds Isolated From Stellera chamaejasme on RBL-2H3 Cells;Natural Product Communications;2020-07

2. Comparison of efficacy, safety and cost-effectiveness of rupatadine and olopatadine in patients of chronic spontaneous urticaria: A randomized, double-blind, comparative, parallel group trial;Indian Journal of Dermatology;2016

3. Mizolastine;Meyler's Side Effects of Drugs;2016

4. Desloratadine citrate disodium injection, a potent histamine H1 receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades;European Journal of Pharmacology;2015-11

5. International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors;Pharmacological Reviews;2015-06-17